Astera Labs (NASDAQ:ALAB) Stock Price Down 6.5% – What’s Next?

Astera Labs, Inc. (NASDAQ:ALAB) traded down 6.5% during mid-day trading on Tuesday . The stock traded as low as $136.54 and last traded at $138.1250. 714,294 shares traded hands during trading, a decline of 87% from the average session volume of 5,307,236 shares. The stock had previously closed at $147.75.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the stock. Needham & Company LLC lifted their price target on shares of Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Roth Capital boosted their target price on Astera Labs from $200.00 to $225.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Stifel Nicolaus upped their price target on Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Wall Street Zen lowered Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. Finally, Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $187.06.

Astera Labs Stock Performance

The business has a 50 day simple moving average of $179.66 and a 200-day simple moving average of $147.90. The firm has a market cap of $26.05 billion, a price-to-earnings ratio of 138.94, a P/E/G ratio of 2.70 and a beta of 1.37.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.39 by $0.10. The firm had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $192.16, for a total transaction of $1,921,600.00. Following the transaction, the general counsel directly owned 151,573 shares of the company’s stock, valued at $29,126,267.68. The trade was a 6.19% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jitendra Mohan sold 90,459 shares of the stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the sale, the chief executive officer owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. This represents a 4.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 586,936 shares of company stock worth $90,628,610. 12.50% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Astera Labs

Several hedge funds have recently modified their holdings of ALAB. Assetmark Inc. boosted its stake in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after buying an additional 101 shares during the last quarter. Oliver Lagore Vanvalin Investment Group bought a new stake in Astera Labs during the second quarter worth $29,000. Bernard Wealth Management Corp. purchased a new position in Astera Labs in the second quarter worth $36,000. National Bank of Canada FI grew its stake in Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after purchasing an additional 124 shares during the period. Finally, Wexford Capital LP purchased a new stake in shares of Astera Labs during the 3rd quarter valued at $39,000. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.